talinolol has been researched along with d-alpha tocopherol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alsenz, J; Bogman, K; Degen, L; Drewe, J; Gutmann, H; Hopfgartner, G; Zysset, Y | 1 |
Belli, S; Elsener, PM; Krämer, SD; Wunderli-Allenspach, H | 1 |
1 trial(s) available for talinolol and d-alpha tocopherol
Article | Year |
---|---|
P-glycoprotein and surfactants: effect on intestinal talinolol absorption.
Topics: Adrenergic beta-Agonists; Adult; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Caco-2 Cells; Cross-Over Studies; Drug Interactions; Half-Life; Humans; Intestinal Absorption; Male; Permeability; Poloxamer; Polyethylene Glycols; Propanolamines; Surface-Active Agents; Vitamin E | 2005 |
1 other study(ies) available for talinolol and d-alpha tocopherol
Article | Year |
---|---|
Cholesterol-mediated activation of P-glycoprotein: distinct effects on basal and drug-induced ATPase activities.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Adenosine Triphosphatases; Adrenergic alpha-Agonists; alpha-Tocopherol; Animals; Anisotropy; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Cell Line, Tumor; Cholesterol; Enzyme Induction; Excipients; Lipid Bilayers; Liposomes; Membranes, Artificial; Mice; Propanolamines; Verapamil; Vinblastine | 2009 |